Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Novo Nordisk A/S (NVO, Financials) cut the price of its top selling weight loss medicine Wegovy in China on Monday, expecting tougher competition from Chinese pharmaceutical businesses when its patent on semaglutide expires in 2026.Local Yicai sources reported list pricing for the two highest Wegovy dosages were dropped by 48% to 987 yuan ($141) and 1,284 yuan per month in Yunnan and Sichuan
The FDA approval of tirzepatide for obstructive sleep apnea is a game-changer in sleep medicine
This is not about willpower or discipline
If you care most about autophagy, take creatine during your eating window
US$ 23.06
US$ 28.77
US$ 25.38
US$ 26.88
